πŸ‡ΊπŸ‡Έ FDA
Patent

US 7087723

Albumin-free factor VIII formulations

granted A61KA61K38/37A61K47/02

Quick answer

US patent 7087723 (Albumin-free factor VIII formulations) held by UNIVERSITY OF CONNECTICUT expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K38/37, A61K47/02, A61K47/10, A61K47/18